Tampa General Hospital first in Florida to adopt Microbot's LIBERTY robotic system

Microbot Medical Inc.

Tampa General Hospital (TGH) becomes first Florida health system to adopt LIBERTY Endovascular Robotic System after FDA 510(k) clearance.
LIBERTY is the only FDA-cleared single-use remotely operated robotic system for peripheral endovascular procedures.
U.S. peripheral endovascular procedures market approximately 2.5 million annually, representing significant commercial opportunity.
Limited market release began late 2025; full market release planned at SIR conference in April 2026.
CEO Harel Gadot cites TGH's innovation culture as endorsement of LIBERTY's value and market relevance.

item 7.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001493152-26-007827
form_type: 8-K
ticker: MBOT
cik: 0000883975
company_name: Microbot Medical Inc.
filed_at: 2026-02-24T23:59:59+00:00
discovered_at: 2026-05-14T18:02:37.910499+00:00
generated_at: 2026-05-16T00:59:41.962327+00:00
sec_items: ["7.01", "9.01"]
event_type: other_material
sentiment: positive
materiality_score: 0.6
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001493152-26-007827
json_url: https://secwatch.observer/filing/0001493152-26-007827.json
markdown_url: https://secwatch.observer/filing/0001493152-26-007827.md
text_url: https://secwatch.observer/filing/0001493152-26-007827.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/883975/000149315226007827/0001493152-26-007827-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/883975/000149315226007827/form8-k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001493152-26-007827

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.